Position in LLY
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$46,530,691
+$18,245,005 QoQ
Shares Held
38,794
+26.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#574
of 4,621 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Liontrust Investment Partners LLP holds $347,446,253 across 2 Drug Manufacturers - General names. LLY ranks #2 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,586,940 | $300,915,562 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
38,794 | $46,530,691 |
All Filings in LLY
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,530,691 | 38,794 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $28,285,686 | 30,753 | Shares | Sole | 2026-05-20 | |
| 2025-12-31 | $22,530,668 | 20,965 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $41,092,128 | 53,856 | Shares | Sole | 2025-11-24 | |
| 2025-06-30 | $42,920,921 | 55,060 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $26,064,893 | 31,559 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $30,297,140 | 39,245 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $22,591,470 | 25,500 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $23,087,190 | 25,500 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $17,504,100 | 22,500 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $19,236,360 | 33,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,325,515 | 15,500 | Shares | Sole | 2023-11-09 | |
| No filing history on record for this holder in this stock. | ||||||